查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1612898

細胞化驗分析市場：按產品供應、應用和最終用戶 - 2025-2030 年全球預測

Cell-based Assay Market by Offerings (Consumables, Instruments, Services), Application (Basic Research, Drug Discovery), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年，細胞化驗分析市值為206.4億美元，預計到2024年將達到222.8億美元，複合年成長率為8.11%，到2030年將達到356.5億美元。

細胞化驗分析是主要用於藥物發現和開發的關鍵工具，為細胞機制和生物活性化合物的相互作用提供了重要的見解。這些測定對於從生理角度測試新藥化合物的功效和毒性至關重要，為製藥和生物技術領域做出了重大貢獻。應用範圍包括高通量篩檢、自動化處理和各種生物過程的測試，包括細胞活力、增殖、細胞毒性和訊號傳導。最終用途包括製藥公司、學術機構、實驗室和生技公司，利用這些分析來簡化藥物開發平臺。

主要市場統計
基準年[2023] 206.4億美元
預測年份 [2024] 222.8億美元
預測年份 [2030] 356.5億美元
複合年成長率（%） 8.11%

由於對精準醫療的需求不斷增加、自動化程度的提高以及提供全面資料分析的先進成像和分析工具的整合，基於細胞的檢測市場正在經歷強勁成長。生技藥品和個人化醫療的興起進一步擴大了這些檢測的效用。值得注意的是，產業主要企業之間的策略聯盟和夥伴關係是推動創新和市場擴張的關鍵成長要素。然而，先進檢測試劑套件的高成本和嚴格的法律規範等挑戰可能會構成主要障礙並限制市場擴張。

3D 細胞培養和器官晶片模型的開發存在著巨大的機遇，它們代表了複雜的生理相關體外測試系統的下一個前沿領域。提高檢測靈敏度，再加上用於資料處理的人工智慧 (AI) 和機器學習 (ML) 的整合，為創新提供了令人興奮的途徑。為了利用這些機會，公司應該投資研發以改善檢測技術，並尋求策略聯盟以實現技術共用和市場滲透。儘管前景光明，但市場相關人員必須克服營運挑戰，包括成本控制和監管合規性，以維持成長。透過專注於這些策略，公司可以利用細胞化驗分析市場的巨大潛力，並將自己定位為未來生物醫學研究的領導者。

市場動態：揭示快速發展的細胞化驗分析市場的關鍵市場洞察

供需的動態交互作用正在改變細胞化驗分析市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • 慢性病的發展以及藥物發現和開發活動的擴大
    • 擴大全球研究活動並資助藥物研究
    • 個人化醫療的普及和客製化細胞化驗分析的需求
  • 市場限制因素
    • 使用細胞化驗分析的複雜性和缺乏熟練人員
  • 市場機會
    • 持續創新以提高細胞化驗分析的準確性、效率和性能
    • 採用細胞化驗分析作為檢測特定疾病的診斷工具
  • 市場挑戰
    • 細胞化驗分析的性能限制和技術限制

波特五力：駕馭細胞化驗分析市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解細胞化驗分析市場的外部影響

外部宏觀環境因素在塑造細胞化驗分析市場的績效動態方面發揮關鍵作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解細胞化驗分析市場的競爭格局

細胞化驗分析市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣細胞化驗分析市場供應商的績效評估

FPNV定位矩陣是評估細胞化驗分析市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了細胞化驗分析市場的成功之路

細胞化驗分析市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 慢性病的增加以及藥物發現和開發活動的擴大
      • 擴大對全球研究活動的關注並資助藥物研究
      • 個人化醫療的普及和客製化細胞檢測的需求
    • 抑制因素
      • 使用基於細胞的檢測的複雜性和缺乏熟練人員
    • 機會
      • 持續創新以提高細胞檢測的準確性、效率和性能
      • 採用以細胞為基礎的檢測作為診斷工具來檢測特定疾病
    • 任務
      • 基於細胞的檢測的性能限制和技術限制
  • 市場區隔分析
    • 我們提供什麼：擴大細胞檢測耗材的創新，這些耗材在執行細胞檢測中發揮重要作用
    • 最終用戶：製藥和生物技術公司在藥物開發過程中廣泛使用基於細胞的檢測方法
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章細胞化驗分析市場產品

  • 消耗品
    • 檢測試劑套件
    • 細胞株
    • 微孔盤
    • 探針和標籤
    • 試劑
  • 裝置
  • 服務

第7章細胞化驗分析市場：依應用分類

  • 基礎研究
  • 藥物發現
    • 動態研究
    • 藥物動力學研究
    • 毒性研究

第8章細胞化驗分析市場：依最終用戶分類

  • 學術和政府機構
  • 合約調查機構
  • 製藥和生物技術公司

第9章美洲細胞化驗分析市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太細胞化驗分析市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲的細胞化驗分析市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • ARRALYZE 推出 CellShepherd，這是一個完全自主的單細胞平台，用於即時監測功能測定。
    • InSphero 與 ATCC 合作，透過先進的 3D 細胞檢測徹底改變腫瘤學研究
    • Beckman Coulter Life Sciences 和 10x Genomics 合作夥伴
  • 戰略分析和建議

公司名單

  • Abnova Corporation
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Canvax Reagents SL
  • Cell Biolabs, Inc.
  • Cell Signaling Technology, Inc.
  • Charles River Laboratories, Inc.
  • Corning Inc.
  • Danaher Corporation
  • Elabscience Bionovation Inc.
  • Enzo Life Sciences, Inc.,
  • Eurofins Scientific SE
  • GE HealthCare Technologies Inc.
  • InSphero AG
  • Intertek Group plc
  • InvivoGen
  • Lonza Group Ltd.
  • Merck KGaA
  • Molecular Devices, LLC.
  • Perkinelmer, Inc.
  • Promega Corporation
  • ReadyCell, SL
  • Sartorius AG
  • Thermo Fisher Scientific Inc.
Product Code: MRR-436B79517C3D

The Cell-based Assay Market was valued at USD 20.64 billion in 2023, expected to reach USD 22.28 billion in 2024, and is projected to grow at a CAGR of 8.11%, to USD 35.65 billion by 2030.

Cell-based assays are pivotal tools utilized predominantly in drug discovery and development, providing critical insights into cellular mechanisms and the interactions of biologically active compounds. These assays are essential for testing the efficacy and toxicity of new drug compounds in a physiological context, significantly contributing to the pharmaceutical and biotechnology sectors. Their application extends across high-throughput screening, automated handling, and the testing of various biological processes, including cell viability, proliferation, cytotoxicity, and signal transduction. The end-use spectrum covers pharmaceutical companies, academic institutes, research labs, and biotechnology firms, which leverage these assays to streamline the drug development pipeline.

KEY MARKET STATISTICS
Base Year [2023] USD 20.64 billion
Estimated Year [2024] USD 22.28 billion
Forecast Year [2030] USD 35.65 billion
CAGR (%) 8.11%

The market for cell-based assays is experiencing robust growth, driven by increasing demand for precision medicine, advancements in automation, and the integration of advanced imaging and analytical tools that offer comprehensive data analysis. The rise of biologics and personalized medicine has further expanded the utility of these assays. Notably, strategic collaborations and partnerships among key players in the industry are pivotal growth factors, fostering innovation and market expansion. However, challenges such as high costs of advanced assay kits and stringent regulatory frameworks pose significant obstacles, potentially restraining market progression.

Remarkable opportunities exist in the development of 3D cell cultures and organ-on-chip models, representing the next frontier of sophisticated and physiologically relevant in vitro testing systems. Enhanced assay sensitivity, coupled with artificial intelligence (AI) and machine learning (ML) integration for data processing, presents a ground-breaking avenue for innovation. To capitalize on these opportunities, businesses should invest in R&D to refine assay technologies and pursue strategic alliances for technology sharing and market penetration. Despite the promising outlook, market players must navigate operational challenges, including cost containment and regulatory compliance, to sustain growth. By focusing on these strategies, companies can harness the extensive potential within the cell-based assays market, positioning themselves as leaders in the future of biomedical research.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cell-based Assay Market

The Cell-based Assay Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of chronic diseases and growing drug discovery and development activities
    • Expanding focus on research activities across the world and funding for pharmaceutical research
    • Proliferation of personalized medicine and the demand for customized cell-based assays
  • Market Restraints
    • Complexities in the usage of cell-based assays and lack of skilled personnel
  • Market Opportunities
    • Ongoing innovations to improve the accuracy, efficiency, and performance of cell-based assays
    • Adoption of cell-based assays as a diagnostic tool for detecting certain diseases
  • Market Challenges
    • Performance limitations and technical constraints of cell-based assays

Porter's Five Forces: A Strategic Tool for Navigating the Cell-based Assay Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cell-based Assay Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cell-based Assay Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cell-based Assay Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cell-based Assay Market

A detailed market share analysis in the Cell-based Assay Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cell-based Assay Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cell-based Assay Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cell-based Assay Market

A strategic analysis of the Cell-based Assay Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cell-based Assay Market, highlighting leading vendors and their innovative profiles. These include Abnova Corporation, Agilent Technologies, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Canvax Reagents S.L., Cell Biolabs, Inc., Cell Signaling Technology, Inc., Charles River Laboratories, Inc., Corning Inc., Danaher Corporation, Elabscience Bionovation Inc., Enzo Life Sciences, Inc.,, Eurofins Scientific SE, GE HealthCare Technologies Inc., InSphero AG, Intertek Group plc, InvivoGen, Lonza Group Ltd., Merck KGaA, Molecular Devices, LLC., Perkinelmer, Inc., Promega Corporation, ReadyCell, S.L., Sartorius AG, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Cell-based Assay Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Offerings, market is studied across Consumables, Instruments, and Services. The Consumables is further studied across Assay Kits, Cell Lines, Microplates, Probes & Labels, and Reagents.
  • Based on Application, market is studied across Basic Research and Drug Discovery. The Drug Discovery is further studied across Pharmacodynamic Studies, Pharmacokinetic Studies, and Toxicity Studies.
  • Based on End-User, market is studied across Academic & Government Institutes, Contract Research Organizations, and Pharmaceutical & Biotechnology Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of chronic diseases and growing drug discovery and development activities
      • 5.1.1.2. Expanding focus on research activities across the world and funding for pharmaceutical research
      • 5.1.1.3. Proliferation of personalized medicine and the demand for customized cell-based assays
    • 5.1.2. Restraints
      • 5.1.2.1. Complexities in the usage of cell-based assays and lack of skilled personnel
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing innovations to improve the accuracy, efficiency, and performance of cell-based assays
      • 5.1.3.2. Adoption of cell-based assays as a diagnostic tool for detecting certain diseases
    • 5.1.4. Challenges
      • 5.1.4.1. Performance limitations and technical constraints of cell-based assays
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Offerings: Expanding innovations in consumables of cell-based assays owing to their essential role in the execution of assays
    • 5.2.2. End-User: Extensive utilization of cell-based assays by pharmaceutical and biotechnology companies for drug development process
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cell-based Assay Market, by Offerings

  • 6.1. Introduction
  • 6.2. Consumables
    • 6.2.1. Assay Kits
    • 6.2.2. Cell Lines
    • 6.2.3. Microplates
    • 6.2.4. Probes & Labels
    • 6.2.5. Reagents
  • 6.3. Instruments
  • 6.4. Services

7. Cell-based Assay Market, by Application

  • 7.1. Introduction
  • 7.2. Basic Research
  • 7.3. Drug Discovery
    • 7.3.1. Pharmacodynamic Studies
    • 7.3.2. Pharmacokinetic Studies
    • 7.3.3. Toxicity Studies

8. Cell-based Assay Market, by End-User

  • 8.1. Introduction
  • 8.2. Academic & Government Institutes
  • 8.3. Contract Research Organizations
  • 8.4. Pharmaceutical & Biotechnology Companies

9. Americas Cell-based Assay Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Cell-based Assay Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Cell-based Assay Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. ARRALYZE launches CellShepherd, a fully autonomous single-cell platform for real-time monitoring of functional assays
    • 12.3.2. InSphero To Revolutionize Oncology Research Through Advanced 3D Cell-Based Assays With ATCC
    • 12.3.3. Beckman Coulter Life Sciences and 10x Genomics Partner
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abnova Corporation
  • 2. Agilent Technologies, Inc.
  • 3. Becton, Dickinson and Company
  • 4. Bio-Rad Laboratories, Inc.
  • 5. Canvax Reagents S.L.
  • 6. Cell Biolabs, Inc.
  • 7. Cell Signaling Technology, Inc.
  • 8. Charles River Laboratories, Inc.
  • 9. Corning Inc.
  • 10. Danaher Corporation
  • 11. Elabscience Bionovation Inc.
  • 12. Enzo Life Sciences, Inc.,
  • 13. Eurofins Scientific SE
  • 14. GE HealthCare Technologies Inc.
  • 15. InSphero AG
  • 16. Intertek Group plc
  • 17. InvivoGen
  • 18. Lonza Group Ltd.
  • 19. Merck KGaA
  • 20. Molecular Devices, LLC.
  • 21. Perkinelmer, Inc.
  • 22. Promega Corporation
  • 23. ReadyCell, S.L.
  • 24. Sartorius AG
  • 25. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. CELL-BASED ASSAY MARKET RESEARCH PROCESS
  • FIGURE 2. CELL-BASED ASSAY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CELL-BASED ASSAY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS CELL-BASED ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS CELL-BASED ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES CELL-BASED ASSAY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES CELL-BASED ASSAY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC CELL-BASED ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC CELL-BASED ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CELL-BASED ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CELL-BASED ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. CELL-BASED ASSAY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. CELL-BASED ASSAY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CELL-BASED ASSAY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CELL-BASED ASSAY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CELL-BASED ASSAY MARKET DYNAMICS
  • TABLE 7. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY ASSAY KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY CELL LINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY MICROPLATES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY PROBES & LABELS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY BASIC RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY PHARMACODYNAMIC STUDIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY PHARMACOKINETIC STUDIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY TOXICITY STUDIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY ACADEMIC & GOVERNMENT INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS CELL-BASED ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES CELL-BASED ASSAY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC CELL-BASED ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA CELL-BASED ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 237. CELL-BASED ASSAY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 238. CELL-BASED ASSAY MARKET, FPNV POSITIONING MATRIX, 2023